Market Research Report
Global Endovascular Aneurysm Repair (EVAR) Market Report: 2015 Edition
|Published by||Koncept Analytics||Product code||349911|
|Published||Content info||52 Pages
|Global Endovascular Aneurysm Repair (EVAR) Market Report: 2015 Edition|
|Published: January 15, 2016||Content info: 52 Pages||
An abdominal aortic aneurysm (AAA) is a localized bulging or abnormal enlargement of the abdominal aorta (the largest artery in the human body), most often the infrarenal and aorto-iliac arteries. AAAs occur most often in Caucasian males over the age of 65 years; they are less common in women.
Endovascular aneurysm repair (EVAR) is a minimally invasive alternative to major open surgery for the repair of AAA's that results in reduced recovery times and potentially improved survival rates. It is a type of endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA). Endovascular procedures aim to reduce the morbidity and mortality of treating arterial disease in a patient population that is increasingly older and less fit than when major open repairs were developed and popularized.
Growing numbers of geriatric population and associated expenditure for health care, steadily increasing cases of AAA screening worldwide are likely to fuel growth over the coming years. Postoperative complications like Endoleaks and migration is the biggest challenge faced by the industry. Also the growing number of regulations posed by regulatory authorities like FDA restricts the industry players. Some of the trends impacting the market include ongoing clinical studies, growing use of percutaneous EVAR, preferences for various AAA repair methods, and technological developments.
This report assesses the global EVAR market in terms of both market volume and market value on the global and regional level. The increasing competition in the EVAR industry has been analyzed on a variety of factors: revenue, surgical outcomes, postoperative procedures and complications. The top three companies having a vicious competition with each other and dominating the EVAR industry are- Medtronic, TriVascular and Lombard Medical. These players are being profiled in the report along with their key financials and strategies for growth.